Blood test could predict cancer return after surgery

NCT ID NCT03637686

Ongoing Knowledge-focused Sponsor: University of Aarhus Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a simple blood test can find tiny bits of cancer DNA left in the body after surgery for colorectal cancer. The goal is to identify patients at high risk of the cancer coming back, so doctors can adjust follow-up care. Over 3,000 people with stage I-III colorectal cancer are taking part. The test is not a treatment itself, but a way to better understand and monitor the disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colorectal cancer colorectal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COLORECTAL CANCER

Contacts and locations

Locations

Aalborg University Hospital

Aalborg, North Denmark, 9000, Denmark
Aarhus University Hospital

Aarhus, 8000, Denmark
Bispebjerg Hospital

Copenhagen, 2400, Denmark
Herlev Hospital

Herlev, 2730, Denmark
Odense University Hospital

Odense, The Region of Southern Denmark, 5000, Denmark
Regional Hospital Horsens

Horsens, 8700, Denmark
Regional Hospital Randers

Randers, 8930, Denmark
Regional Hospital Viborg

Viborg, 8800, Denmark
Regional Hospital West Jutland

Herning, 7400, Denmark
Zealand University Hospital

Køge, 4600, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.